A Study to Learn About Patients With Non-Small Cell Lung Cancer (NSCLC) Who Took Lorlatinib as Their First Treatment
Clinical trial NCT07567352 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07567352
- Sponsor
- Pfizer
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-05-01
- Primary completion
- 2026-07-31
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.